Nilofer Saba Azad

Dr. Nilofer Saba Azad enhances global conversations on gastrointestinal oncology through her extensive research and clinical expertise. As an associate professor of oncology at the prestigious Johns Hopkins University School of Medicine, she is recognized for her specialization in gastrointestinal cancers, including colorectal, pancreatobiliary, bile duct cancer, cholangiocarcinoma, and pancreatic cancer. Her work is pivotal in advancing the understanding and treatment of these complex diseases. Dr. Azad leads the Developmental Therapeutics Clinical Trials Program, where she plays a crucial role in pioneering new treatment modalities and therapeutic strategies. Her leadership extends to her role as Co-Director of Cancer Genetics and Epigenetics, where she collaborates with fellow researchers to explore the genetic and epigenetic underpinnings of cancer, aiming to translate these findings into clinical applications. Her academic journey began with a medical degree from Baylor College of Medicine, followed by a residency in internal medicine. She further honed her expertise with a fellowship in oncology and hematology at the National Cancer Institute, part of the National Institutes of Health. Her dedication to the field is underscored by her board certification in medical oncology from the American Board of Internal Medicine. Dr. Azad's research interests are deeply rooted in the exploration of epigenetics and cancer genetics, with a particular focus on clinical trials that seek to improve patient outcomes. Her work in these areas contributes significantly to the evolving landscape of cancer treatment, offering hope and innovative solutions to patients worldwide. In addition to her research and clinical duties, Dr. Azad is committed to mentoring the next generation of oncologists and researchers. Her passion for education and her dedication to her students and colleagues make her a respected figure in the academic and medical communities. Through her tireless efforts in research, clinical practice, and education, Dr. Nilofer Saba Azad continues to make significant contributions to the field of oncology, impacting the lives of countless patients and advancing the global understanding of cancer.